SibyllaBiotech

Today we officially welcome Dr. Dominique Bridon as Executive Chairman of our Board of Directors! With 30+ years in #pharma, #biotech, and expertise in #AI-based #drugdevelopment, he’ll aid in expanding our innovative protein degrader pipeline. #foldthefuture

#WorldHealthDay reminds us of the importance of providing #HealthForAll. We're contributing to this goal by developing our PPI-FIT tech, designed to provide access to a range of undruggable targets. Visit bit.ly/2HC0KJi for more on #WHO75 #sibylla to #foldthefuture

#SaveTheDate: next week our CEO @PieriLidia, our CTO @Giovann01476075, and Sophye El-Hayek will attend the 3rd Annual #TPDEurope Summit, in London. Giovanni will present #Sibylla and the PPI-FIT computational drug discovery technology. bit.ly/40V5BeL #foldthefuture

Schedule a meeting with our CTO, @Giovann01476075 and our Medchem Principal Scientist Leda Bencheva, next week at #BIOEuropeSpring in Basel, March 20-22. Connect with them to learn more about #Sibylla and the potential of our innovative #proteinfolding technology #foldthefuture

Tomorrow we fly to Boston! Meet our CEO, @PieriLidia and our CTO, @Giovann01476075, at the 4th Annual Protein Degradation & Targeting Undruggables Congress. Learn more about the #PDTU here: bit.ly/40XBV0j

Sibylla celebrates the inclusion and visibility of women across all industries. This #IWD2023 we encourage others to fully #EmbraceEquity and celebrate the achievements of women around them. Find out how you can help #breakthebias and #foldthefuture at: bit.ly/3SoT3bJ

#MeetTheTeam #Sibylla #foldthefuture linkedin.com/feed/update/ur…

#DidYouKnow that #TechnologyTransfer between universities & startups can pose many complicated challenges that require a strong, cohesive team to address? Visit sibyllabiotech.it/our-story/ and learn more about the scientific inception of #sibylla

Meet our very first employee, Alberto! #foldthefuture #WeAreSibyllians #MeetTheTeam linkedin.com/feed/update/ur…

Join our CEO, @PieriLidia , in New York City for the #BIOCEO23 Conference at Feb 7, 10:30 AM ET, where she will be presenting an overview of our innovative PPI-FIT technology and recent corporate developments.

Starting the week on a high note by introducing the people that forge Sibylla. We start with one of our #WomenInSTEM, engaged in our mission to #FoldtheFuture! linkedin.com/posts/sibyllab…

Raising children while working is no easy feat! Yet, children are never a problem and parenting cannot be a drawback. We are rolling out special parental benefits at Sibylla to support our teammates who have or will have children. #CompanyCulture #FoldtheFuture

Let’s explore the importance of technology transfer. In the following months, we’ll share our experience shifting from research to #startup & how this enabled our PPI-FIT platform to come to life & drives growth as we work toward ameliorating #drugdiscovery. #FoldtheFuture

New year, new scene for Sibylla! Happy to announce our relocation to business & biotech hub, Milan, an important life sciences cluster in Europe & home to an array of international biotechs & renowned research institutions. Stay tuned for further growth updates! #FoldtheFuture

Do you want to see our PPI-FIT technology in action? Watch our video to learn how we are unlocking a completely new strategy for drug design by targeting proteins while they are still in the folding process: bit.ly/3TGvslH

Happy Holidays from the entire Sibylla team!

Why are we called “Sibylla?” We are named after the Greek oracle gifted in making accurate prophecies. Our team strives to be as successful in predicting where we can drug the pockets of degrading proteins using our PPI-FIT platform. More at sibyllabiotech.it

twitter.com/Labiotech_eu/s… Thanks @Labiotech_eu for featuring us in your newsletter on startups & for interviewing us on how our team, made of physicists & biologists, came together to create Sibylla to improve drug discovery with our PPI-FIT technology. sibyllabiotech.it

We will be on-site at the Inaugural #TPD Assay Development & Screening Summit in San Diego from Dec 6 – 8. Meet with us to learn about how we are applying our PPI-FIT platform to perform protein folding pathway simulations to unveil a new class of folding interfering degraders.